Home Biosimilar Antibodies Protein Tyrosine Kinase IGF-1R antibody Robatumumab (Anti-IGF1R / CD221) For research use only.
Not for use in humans.

Robatumumab (Anti-IGF1R / CD221)

Synonyms: Sch 717454

Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD

Robatumumab (Anti-IGF1R / CD221)

Purity & Quality Control

≥99

Choose Selective IGF-1R Inhibitors

Biological Activity

Description Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD

Product Details

CAS No. 934235-44-6
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Robatumumab (Anti-IGF1R / CD221) | Robatumumab (Anti-IGF1R / CD221) supplier | purchase Robatumumab (Anti-IGF1R / CD221) | Robatumumab (Anti-IGF1R / CD221) cost | Robatumumab (Anti-IGF1R / CD221) manufacturer | order Robatumumab (Anti-IGF1R / CD221) | Robatumumab (Anti-IGF1R / CD221) distributor